Get the latest Science News and Discoveries

New Hope for Lung Cancer Patients: FDA Grants Special Status to NVL-655

Key Takeaways - FDA grants Breakthrough Therapy Designation to NVL-655 for ALK-positive NSCLC. - Preliminary trial shows NVL-655 shrinks tumors in nearly half of patients.

None

Get the Android app